Leopoldo Nicolas Segal

NYU Grossman School of Medicine

NIH Rank #5592
  • Program Leader
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$2M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#5,592
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2M across 4 grants · National rank #5592.

Top grants by award amount

Leopoldo Nicolas Segal's NIH grant portfolio, ranked by award amount.

  • 4R33GM147800-03R33
    BIOREPOSITORY OPTIMIZATION AND USE FOR ENDOTYPING CRITICALLY ILL SARS-COV-2 INFECTED PATIENTS
    $743.7K
    award amount
  • 5R37CA244775-05R37
    Local microbiota signatures of pro-tumor immunity and checkpoint inhibition susceptibility in lung cancer
    $596.6K
    award amount
  • 1U01AG088351-01U01
    Age related loss of immune resilience during response to severe respiratory viral infections
    $528K
    award amount
  • 5U2CCA271890-02U2C
    Microbial and host biomarker development for detection and prognosis of early stage non-small cell lung cancer
    $85.4K
    award amount

Affiliation

Institutions that have administered grants for Leopoldo Nicolas Segal.

Affiliated with NYU Grossman School of Medicine (NY).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    NYU Grossman School of Medicine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5592